Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Equity Ratio (2021 - 2025)

Bioregenx has reported Equity Ratio over the past 5 years, most recently at 11.04 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 66.14% year-over-year to 11.04; the TTM value through Dec 2025 reached 11.04, down 66.14%, while the annual FY2025 figure was 11.04, 66.14% down from the prior year.
  • Equity Ratio for Q4 2025 was 11.04 at Bioregenx, down from 3.12 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.81 in Q1 2024 and troughed at 82.34 in Q3 2023.
  • A 5-year average of 15.59 and a median of 4.91 in 2024 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: tumbled 6382.36% in 2022 and later skyrocketed 102.63% in 2024.
  • Year by year, Equity Ratio stood at 0.66 in 2021, then crashed by 6382.36% to 42.74 in 2022, then skyrocketed by 94.4% to 2.39 in 2023, then plummeted by 177.73% to 6.65 in 2024, then plummeted by 66.14% to 11.04 in 2025.
  • Business Quant data shows Equity Ratio for BRGX at 11.04 in Q4 2025, 3.12 in Q3 2025, and 3.18 in Q2 2025.